| pubmed-article:8223990 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8223990 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8223990 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8223990 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:8223990 | lifeskim:mentions | umls-concept:C0549473 | lld:lifeskim |
| pubmed-article:8223990 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:8223990 | lifeskim:mentions | umls-concept:C1412791 | lld:lifeskim |
| pubmed-article:8223990 | lifeskim:mentions | umls-concept:C1413306 | lld:lifeskim |
| pubmed-article:8223990 | lifeskim:mentions | umls-concept:C0439230 | lld:lifeskim |
| pubmed-article:8223990 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8223990 | pubmed:dateCreated | 1993-12-20 | lld:pubmed |
| pubmed-article:8223990 | pubmed:abstractText | In the present short paper we compared the BGP and AP levels of 26 patients with thyroid carcinoma during radio-iodine therapy. BGP values reflect the bone turnover before and after radio-iodine therapy. There were no significant AP changes during this period. These results suggest that thyroid hormone has a direct effect on osteoblast function and that this effect can be best monitored by determination of BGP levels. | lld:pubmed |
| pubmed-article:8223990 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8223990 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8223990 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8223990 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8223990 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8223990 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8223990 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8223990 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8223990 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8223990 | pubmed:issn | 0232-7384 | lld:pubmed |
| pubmed-article:8223990 | pubmed:author | pubmed-author:FederlinKK | lld:pubmed |
| pubmed-article:8223990 | pubmed:author | pubmed-author:StrackeHH | lld:pubmed |
| pubmed-article:8223990 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8223990 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:8223990 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8223990 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8223990 | pubmed:pagination | 186-8 | lld:pubmed |
| pubmed-article:8223990 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:meshHeading | pubmed-meshheading:8223990-... | lld:pubmed |
| pubmed-article:8223990 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8223990 | pubmed:articleTitle | BGP serum levels in patients with thyroid carcinoma before and 4-14 weeks after radioiodine therapy. | lld:pubmed |
| pubmed-article:8223990 | pubmed:affiliation | Third Medical Department, University of Giessen, Federal Republic of Germany. | lld:pubmed |
| pubmed-article:8223990 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8223990 | pubmed:publicationType | Comparative Study | lld:pubmed |
